budesonide
budesonide is listed in the FDA National Drug Code directory with 16 NDC codes, marketed under brand names including budesonide, BUDESONIDE, Uceris. Available dosage forms: tablet, extended release, capsule, coated pellets, aerosol, foam, capsule, capsule, delayed release.
Drug details
- Generic Name
- budesonide
- Brand Names
- budesonide, BUDESONIDE, Uceris, Tarpeyo
- Application Number
- NDA203634
- Sponsor
- Oceanside Pharmaceuticals
- NDC Codes
- 16
- Dosage Forms
- TABLET, EXTENDED RELEASE, CAPSULE, COATED PELLETS, AEROSOL, FOAM, CAPSULE, CAPSULE, DELAYED RELEASE
- Routes
- ORAL, RECTAL
- Active Ingredients
- BUDESONIDE
Indications and Usage
1 INDICATIONS AND USAGE Budesonide inhalation suspension is an inhaled corticosteroid indicated for: Maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age ( 1 ) Limitations of Use: Not indicated for the relief of acute bronchospasm ( 1 ) 1.1 Maintenance Treatment of Asthma Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age. Limitations of Use: Budesonide inhalation suspension is NOT indicated for the relief of acute bronchospasm.